Further studies are needed to evaluate the effectiveness of therapeutic hypothermia in children. The design of these studies should account for current pediatric intensive care unit (ICU) practice and attitudes of intensivists regarding the appropriateness of conducting a randomized clinical trial in a high-risk population. Specifically, because there are convincing data in adults and early data showing a beneficial effect of therapeutic hypothermia in newborns, is there still clinical equipoise to conduct a randomized, controlled trial in children? This survey was designed to answer these questions as part of a planning project for a multiple-center, randomized, controlled trial of therapeutic hypothermia for comatose survivors of pediatric cardiac arrest. We designed a survey instrument to gather information in the following areas from the pediatric critical care community: 1) How many physicians are aware of and use therapeutic hypothermia in children after cardiac arrest? 2) If hypothermia was used, what was the methodology related to timing, duration, method of induction, and rewarming? 3) What was the consensus on the need for a randomized trial and willingness to participate if a trial was conducted?
MATERIALS AND METHODS
The study protocol was approved by the University of Florida Health Science Center Institutional Review Board. The study was deemed compliant with the Health Insurance Portability and Accountability Act of 1996 (HIPPA) regulations.
Study Design and Selection of Participants.
The planning committee identified key questions, which were prepared in a paper survey format and distributed to the planning committee for feedback. After this revision, the paper survey was pilot tested at the annual meeting of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI), held in New York in October 2004. Based on feedback from this group, the survey was further modified and produced in its final form using Webbased survey software (Zoomerang, http:// www.zoomerang.com). The survey (Appendix) was designed to facilitate completion using radio button selections, drop-down lists, and Likert responses, along with free text entries for specific queries.
Survey Execution. A request to complete the Internet-based survey was posted to the Pediatric Intensive Care Unit (PICU) Listserver (PICU@listserver.mcw.edu) with a hyperlink to the survey in December 2004. The hyperlink also was placed on the Pediatric Critical Care Website (http://www.Pedsccm.org). A reminder e-mail was posted to the Listserver in early 2005, and the survey was closed on February 1, 2005. The PICU list currently has approximately 1,300 subscribers. There were 33 questions. The first 22 pertained to knowledge and attitude about therapeutic hypothermia and the feasibility to conduct a randomized trial; the remaining 11 questions collected demographic information related to the respondent's training and work environment. No personally identifiable information was obtained.
Primary Data Analysis. Survey response data were imported into Microsoft Excel (Microsoft, Seattle, WA) for subsequent data analysis. Most results are presented as the percentage of survey responders; some values are reported as mean Ϯ SD where appropriate.
RESULTS

Survey Respondent Demographics.
There were 370 visits to the survey site and 159 surveys completed. As shown in Table 1 , most of the respondents (92%) were fellowship-trained in pediatric critical care. A total of 33 responders (21%) received training in areas other than pediatric critical care. Only nine (6%) are currently in fellowship training. The mean years of critical care experience was 9.9 Ϯ 6.5 yrs (median, 9 yrs; range, 0 -30 yrs).
The mean number of pediatric ICU beds reported by survey responders was 20 Ϯ 11.4, with a range of 4 -80 beds. This question asked for the total number of ICU beds where children are admitted, recognizing that in some centers this may represent more than one physical ICU area. The total annual number of pediatric ICU admissions per year ranged from 100 to 3,750, with a mean of 1,066 Ϯ 569. Two thirds of the responders indicated that their unit admits postoperative open-heart surgery patients.
Most of the respondents (89%) worked in units with resident physicians, whereas 49% worked in a PICU with fellows. Most respondents (85%) were from the United States, with 4% each from Europe and Australia-New Zealand, 3% from Canada, 2% from South America, and 1% each from China, Africa, and Central America.
Knowledge and Attitude About Therapeutic Hypothermia. Overall, 65% of respondents stated that they were very familiar or familiar with the adult therapeutic hypothermia trials, but relatively few (9%) consistently apply hypothermia in comatose children after return of spontaneous circulation. An additional 38% of responders indicate they use hypothermia sometimes. The most commonly reported indication for using hypothermia is the likelihood of postarrest recovery (61% of responses). Absence of life-limiting disease (43%) and presence of coma for Ն1 hr (32%) were additional relatively common indications.
Of the 90 responders who cool patients at least sometimes, the target temperature covered a wide range, as seen in Table 2 . The duration of cooling also covered a wide range; 45 of the 69 responders cool for 12-24 hrs (Table 3) . Only 8 of 69 (11.6%) cool for Ն48 hrs. Once cooled, the vast majority (91%) do not actively rewarm the patient.
Most respondents (97%) actively in- tervene to prevent fever in postarrest patients. The mean threshold temperature at which they intervene was 37.8 Ϯ 0.6°C (median, 38°C; range, 36 -39.5°C). Most (86%) utilize a rectal temperature probe, with one third using a bladder temperature probe. Despite their reported unreliability (25), 25% used tympanic membrane temperature. Study Ethics. The vast majority of responders (95%) indicate they would be willing to randomize comatose survivors of cardiac arrest to hypothermia vs. normothermia. Of those, 65% stated they strongly agreed or agreed that they had clinical equipoise regarding the value of hypothermia vs. normothermia after cardiac arrest. Even if the multiple-center neonatal trials show beneficial effects, the majority of respondents either agree (56%) or strongly agree (25%) that a randomized trial comparing hypothermia with normothermia in pediatric cardiac arrest is still ethical. Because it is impossible to blind providers to the use of hypothermia, 49% of responders realized that this may introduce bias, complicating the ability to conduct a randomized, controlled trial. Overall, many responders either agreed (53%) or strongly agreed (22%) that it is ethically appropriate to randomize children into a hypothermia treatment trial using waiver of informed consent.
Study Methodology. There was no consensus on whether children randomized to a normothermia study group should be actively rewarmed to normal core temperature if they were initially hypothermic. Thirty-nine percent thought they should never be rewarmed, 18% thought that they should be rewarmed sometimes, and 42% thought they always should be rewarmed.
Because at least one of the neonatal trials stratified patients into risk groups based on their EEG early after perinatal asphyxia (20), the ability to obtain an EEG may be important in designing a prospective trial in children. Most respondents can obtain an EEG 24 hrs/day (70%). Despite the general availability of an EEG, just 18% frequently or always use a continuous EEG or processed EEG to monitor comatose children after a cardiac arrest. Only 22% frequently or always load with an anticonvulsant as part of postarrest management. Most responders (71%) always or frequently obtain a computerized tomographic scan or magnetic resonance imaging of the head within the first 72 hrs after the arrest in children who survive for Ͼ24 hrs.
Most (75%) are willing to use neuromuscular blockers in postarrest patients being cooled to prevent rigors, and 74% frequently or always attempt to achieve tight glucose control in critically ill patients, such as those after cardiac arrest.
Of note, 84% would either strongly agree (25%) or agree (59%) with using a standardized treatment protocol to minimize confounding variables in a treatment trial. Somewhat fewer (67%) thought that their partners would comply with a standardized treatment protocol. In addition, 71% would either strongly agree (19%) or agree (52%) with randomizing children into a hypothermia treatment trial that investigates the effect on outcome of different durations of hypothermia or different methods of inducing hypothermia rather than a comparison of hypothermia with normothermia. Finally, 81% thought that therapeutic hypothermia should be studied in other non-cardiac arrest ischemic insults, as shown in Table 4 .
DISCUSSION
Our study shows that a majority of survey participants from the pediatric critical care community are aware of the recent evidence showing a beneficial effect of hypothermia on survival and neurologic outcome after cardiac arrest. Despite this high level of familiarity and the recent International Liaison Committee on Resuscitation (ILCOR) statement (16), use of hypothermia in children is uncommon. Several factors may account for this discrepancy. First, most published evidence is in adults with ventricular fibrillation cardiac arrest and cannot be simply extrapolated to children. Although neonatal trials exists, many of these patients experienced perinatal asphyxia and were not in cardiac arrest at birth but rather in low cardiac output states, severely hypoxic, or both and thus are not directly comparable with pediatric cardiac arrest. In addition, the arrest pathogenesis in neonates does not cover the range of conditions seen in older children, and the duration of perinatal ischemia is likely to be quite variable, depending on whether the cause is related to factors preceding birth. Second, there are no published guidelines recommending the use of therapeutic hypothermia in pediatric cardiac arrest. Finally, there is a lack of consensus on the most effective and safest method to cool, which children should be cooled, how patients should be monitored while cool, the depth and duration of cooling, and the method of rewarming, to name a few of the protocol and technical issues that need to be considered in a treatment trial.
Among those who utilize hypothermia, there is poor agreement regarding the effectiveness of this therapy and the depth and duration of cooling. In addition, there is a lack of consistency in its application to specified patient groups. Our survey suggests that the lack of criteria for application of therapeutic hypothermia is a likely reason for its inconsistent use. As suggested by animal data, hypothermia needs to be achieved within 2-6 hrs of injury to be beneficial (26, 27) . Another study suggested no benefit of hypothermia when it was induced within 8 hrs of traumatic brain injury (28). Thus, the earlier hypothermia is induced, the better its protective effect. Currently, most studies utilize surface cooling with ice packs or a cooling blanket (14, 15, (17) (18) (19) . This approach is slow and logistically difficult, especially in busy emergency departments. An intriguing alternative is the rapid administration of a sizeable bolus of ice-cold isotonic intravenous fluid, which was well tolerated in Respondents could select more than one target temperature range. a preliminary trial in adults and rapidly lowered core body temperature (29).
Animal models of hypoxic-ischemic injury suggest the optimum temperature for neuroprotection is between 32°C and 34°C (30). Below this range, there is increased risk of infection, coagulopathy, thrombocytopenia, renal impairment, and pancreatitis (31, 32). Our survey suggests that although there is a wide variation, the majority who cool their patients select a target temperature in the range of 33-35°C. There is no consensus on the duration of hypothermia, and the rate of rewarming is not actively controlled in most units. Most respondents indicate that they try to not rewarm faster than 1°C/hr, but they admit this is often difficult to control. This variation in rewarming may result from a balanced concern about the known adverse effects of hypothermia on immune function and therefore a desire to minimize the duration of hypothermia balanced by animal and suggestive human data showing that rapid rewarming is associated with greater brain injury. Some experts believe that the benefit of hypothermia observed in a single-center traumatic brain injury study from Pittsburgh (12) occurred because the controls were actively rewarmed at 1°C/hr if they presented with hypothermia. In the subsequent multiple-center trial that failed to demonstrate an overall beneficial effect from hypothermia (28), hypothermic control patients were rewarmed at 0.25°C/hr.
Most respondents thought that a trial of therapeutic hypothermia was important and needed to be studied to gauge the long-term neurologic outcome in children and to gather more convincing data on its safety and effectiveness. Responders realized that the lack of blinding may introduce bias, complicating the ability to conduct a randomized, controlled trial. They also recognized the benefits of initiating hypothermia quickly after return of a stable circulation in adults. Although controversial, they thought it would be ethically appropriate to enroll children in a therapeutic treatment trial using waiver of informed consent. Most would agree to participate in a randomized trial, although interestingly, some of these respondents did not have clinical equipoise regarding the value of therapeutic hypothermia after cardiac arrest.
The majority indicate they would be willing to use a standardized treatment protocol in children with coma after cardiac arrest. This is a key commitment for this type of study because variations in ICU care, such as goals for ventilation, treatment of postarrest myocardial dysfunction, and maintenance of blood glucose concentrations, could influence patient outcome independently of the effects of therapeutic hypothermia. Our survey showed variation in other management interventions, like the routine use of EEGs in postarrest patients, brain imaging studies like computerized tomographic scanning or magnetic resonance imaging, tight glucose control, use of neuromuscular blockade, and prophylactic use of anticonvulsants in postarrest patients. Only 18% of the responders perform EEG evaluation routinely in postarrest patients, although an adult study showed that, overall, 8% of patients in coma (many of whom had a hypoxic or ischemic pathogenesis) had nonconvulsive status epilepticus (33). The rate of nonconvulsive status epilepticus is unknown in comatose children postarrest, which may explain the low rate of prophylactic treatment for seizures, as reported in our survey. A recent study suggested that early head magnetic resonance imaging is useful to help predict outcome in children with hypoxic coma (34). This may have potential value in assessing risk group and outcome for study design.
There are a few limitations of our study. This survey reflects practices prevalent at the time of the survey, which may change as more evidence is published regarding this treatment modality in different population groups. The response rate for our survey was low (about 12%) of the total subscribers. This calculation assumed that all the PICU List subscribers are active, which is likely not the case. In addition, a wide range of providers may subscribe to the Listserver, whereas the vast majority of responses came from physicians. Thus, the 12% response is a "worse-case scenario." The recently published e-mail survey of hypothermia in adult cardiac arrest (35) found that 40% of the 2,000 e-mails they initially selected were not functional. Of the remaining 1,400 e-mail survey requests, their response rate was 19%. Thus, we believe that our response rate is similar to that obtained by Abella et al. (35) and others, particularly because most of our respondents were physicians, whereas nurses and respiratory therapists also subscribe to the PICU list. Unfortunately, we have no way of knowing the exact distribution of list members and how many are still active participants. The majority of our survey respondents were from large hospitals and teaching centers, which may bias the degree to which therapeutic hypothermia is used and may not be generalizable to the entire pediatric intensive care community. Moreover, because the responses were anonymous, we have no way of knowing how representative the responders are of the opinions and approaches used by pediatric intensivists nationally or internationally.
CONCLUSIONS
In summary, we found that the sampled pediatric critical care community, although aware of the beneficial effect of therapeutic hypothermia postarrest, is not widely applying this treatment modality currently. This likely results from the lack of evidence in children, difficulty with the technique, and unavailability of explicit validated treatment protocols. The sampled pediatric critical care com- AVM, arteriovenous malformation; R-L shunt, right-to-left shunt. Multiple responses were permitted, as evident in the total number of responses; the percentage of responses is the percentage of the total responders (n ϭ 145) who chose at least one category. munity recognized the need for a randomized, controlled trial to evaluate the effectiveness of therapeutic hypothermia, and most are willing to participate in such a study. Pediatric studies are needed to assess the safety, feasibility, and efficacy of therapeutic hypothermia after cardiac arrest and other causes of brain injury. 
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